NO853790L - Fremangsmaate for paavisning av immobiliserte raportoergrupper - Google Patents

Fremangsmaate for paavisning av immobiliserte raportoergrupper

Info

Publication number: NO853790L
Authority: NO; Norway
Prior art keywords: component; detector complex; complex; light; reaction
Prior art date: 1984-01-27

Application number

NO853790A

Other languages

English (en)

Norwegian (no)

Inventor

Lyle J Arnold Jr

Original Assignee

Molecular Biosystems Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1984-01-27

Filing date

1985-09-26

Publication date

1985-09-26

1985-09-26 Application filed by Molecular Biosystems Inc filed Critical Molecular Biosystems Inc

1985-09-26 Publication of NO853790L publication Critical patent/NO853790L/no

Links

238000000034 method Methods 0.000 title claims description 116
238000006243 chemical reaction Methods 0.000 claims description 127
125000006853 reporter group Chemical group 0.000 claims description 113
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 91
239000000126 substance Substances 0.000 claims description 66
229960002685 biotin Drugs 0.000 claims description 62
239000011616 biotin Substances 0.000 claims description 62
235000020958 biotin Nutrition 0.000 claims description 50
238000001514 detection method Methods 0.000 claims description 46
102000004190 Enzymes Human genes 0.000 claims description 42
108090000790 Enzymes Proteins 0.000 claims description 42
229940088598 enzyme Drugs 0.000 claims description 42
108090001008 Avidin Proteins 0.000 claims description 38
238000009739 binding Methods 0.000 claims description 36
230000027455 binding Effects 0.000 claims description 33
108090000623 proteins and genes Proteins 0.000 claims description 33
102000004169 proteins and genes Human genes 0.000 claims description 32
239000003153 chemical reaction reagent Substances 0.000 claims description 31
FVTCRASFADXXNN-SCRDCRAPSA-N flavin mononucleotide Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-SCRDCRAPSA-N 0.000 claims description 28
239000000427 antigen Substances 0.000 claims description 27
102000036639 antigens Human genes 0.000 claims description 27
108091007433 antigens Proteins 0.000 claims description 27
102100031126 6-phosphogluconolactonase Human genes 0.000 claims description 25
108010029731 6-phosphogluconolactonase Proteins 0.000 claims description 25
108010018962 Glucosephosphate Dehydrogenase Proteins 0.000 claims description 25
229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 claims description 21
BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 claims description 20
150000001720 carbohydrates Chemical class 0.000 claims description 18
239000002523 lectin Substances 0.000 claims description 18
230000007704 transition Effects 0.000 claims description 18
108090001090 Lectins Proteins 0.000 claims description 17
102000004856 Lectins Human genes 0.000 claims description 17
239000000047 product Substances 0.000 claims description 17
108010090804 Streptavidin Proteins 0.000 claims description 16
229940088594 vitamin Drugs 0.000 claims description 16
229930003231 vitamin Natural products 0.000 claims description 16
235000013343 vitamin Nutrition 0.000 claims description 16
239000011782 vitamin Substances 0.000 claims description 16
230000015572 biosynthetic process Effects 0.000 claims description 15
239000007850 fluorescent dye Substances 0.000 claims description 15
AUTOLBMXDDTRRT-JGVFFNPUSA-N (4R,5S)-dethiobiotin Chemical compound C[C@@H]1NC(=O)N[C@@H]1CCCCCC(O)=O AUTOLBMXDDTRRT-JGVFFNPUSA-N 0.000 claims description 14
108090000363 Bacterial Luciferases Proteins 0.000 claims description 14
MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 14
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 14
239000003446 ligand Substances 0.000 claims description 14
239000001301 oxygen Substances 0.000 claims description 14
229910052760 oxygen Inorganic materials 0.000 claims description 14
150000003722 vitamin derivatives Chemical class 0.000 claims description 14
DEQPBRIACBATHE-FXQIFTODSA-N 5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-2-iminopentanoic acid Chemical compound N1C(=O)N[C@@H]2[C@H](CCCC(=N)C(=O)O)SC[C@@H]21 DEQPBRIACBATHE-FXQIFTODSA-N 0.000 claims description 13
YTNIXZGTHTVJBW-SCRDCRAPSA-N FMNH2 Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2NC2=C1NC(=O)NC2=O YTNIXZGTHTVJBW-SCRDCRAPSA-N 0.000 claims description 13
102000004316 Oxidoreductases Human genes 0.000 claims description 12
108090000854 Oxidoreductases Proteins 0.000 claims description 12
150000001299 aldehydes Chemical class 0.000 claims description 12
239000005515 coenzyme Substances 0.000 claims description 12
239000000470 constituent Substances 0.000 claims description 12
150000001875 compounds Chemical class 0.000 claims description 11
101710088194 Dehydrogenase Proteins 0.000 claims description 10
UFBJCMHMOXMLKC-UHFFFAOYSA-N 2,4-dinitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O UFBJCMHMOXMLKC-UHFFFAOYSA-N 0.000 claims description 9
239000003054 catalyst Substances 0.000 claims description 9
238000004020 luminiscence type Methods 0.000 claims description 9
238000004519 manufacturing process Methods 0.000 claims description 9
GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 claims description 8
239000000758 substrate Substances 0.000 claims description 8
150000001412 amines Chemical class 0.000 claims description 7
230000000670 limiting effect Effects 0.000 claims description 7
VFEXYZINKMLLAK-UHFFFAOYSA-N 2-(trichloromethyl)oxirane Chemical compound ClC(Cl)(Cl)C1CO1 VFEXYZINKMLLAK-UHFFFAOYSA-N 0.000 claims description 6
HUDPLKWXRLNSPC-UHFFFAOYSA-N 4-aminophthalhydrazide Chemical compound O=C1NNC(=O)C=2C1=CC(N)=CC=2 HUDPLKWXRLNSPC-UHFFFAOYSA-N 0.000 claims description 6
239000003795 chemical substances by application Substances 0.000 claims description 6
WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 claims description 6
238000000926 separation method Methods 0.000 claims description 6
230000007306 turnover Effects 0.000 claims description 6
102000007698 Alcohol dehydrogenase Human genes 0.000 claims description 5
108010021809 Alcohol dehydrogenase Proteins 0.000 claims description 5
102000013009 Pyruvate Kinase Human genes 0.000 claims description 5
239000007795 chemical reaction product Substances 0.000 claims description 5
ZFKJVJIDPQDDFY-UHFFFAOYSA-N fluorescamine Chemical compound C12=CC=CC=C2C(=O)OC1(C1=O)OC=C1C1=CC=CC=C1 ZFKJVJIDPQDDFY-UHFFFAOYSA-N 0.000 claims description 5
HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 claims description 5
229910052751 metal Inorganic materials 0.000 claims description 5
239000002184 metal Substances 0.000 claims description 5
150000003573 thiols Chemical class 0.000 claims description 5
IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 claims description 4
102000003992 Peroxidases Human genes 0.000 claims description 4
102000004357 Transferases Human genes 0.000 claims description 4
108090000992 Transferases Proteins 0.000 claims description 4
238000005859 coupling reaction Methods 0.000 claims description 4
239000013067 intermediate product Substances 0.000 claims description 4
108040007629 peroxidase activity proteins Proteins 0.000 claims description 4
NGVDGCNFYWLIFO-UHFFFAOYSA-N pyridoxal 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O NGVDGCNFYWLIFO-UHFFFAOYSA-N 0.000 claims description 4
FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 claims description 4
XTWYTFMLZFPYCI-KQYNXXCUSA-N 5'-adenylphosphoric acid Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XTWYTFMLZFPYCI-KQYNXXCUSA-N 0.000 claims description 3
ZHBOFZNNPZNWGB-UHFFFAOYSA-N 9,10-bis(phenylethynyl)anthracene Chemical compound C1=CC=CC=C1C#CC(C1=CC=CC=C11)=C(C=CC=C2)C2=C1C#CC1=CC=CC=C1 ZHBOFZNNPZNWGB-UHFFFAOYSA-N 0.000 claims description 3
ZKHQWZAMYRWXGA-KQYNXXCUSA-N Adenosine triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-N 0.000 claims description 3
108020000543 Adenylate kinase Proteins 0.000 claims description 3
102000002281 Adenylate kinase Human genes 0.000 claims description 3
102000002260 Alkaline Phosphatase Human genes 0.000 claims description 3
108020004774 Alkaline Phosphatase Proteins 0.000 claims description 3
108010062580 Concanavalin A Proteins 0.000 claims description 3
102000004420 Creatine Kinase Human genes 0.000 claims description 3
108010042126 Creatine kinase Proteins 0.000 claims description 3
SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 claims description 3
CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 claims description 3
108090000331 Firefly luciferases Proteins 0.000 claims description 3
BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 claims description 3
PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 claims description 3
108010015776 Glucose oxidase Proteins 0.000 claims description 3
239000004366 Glucose oxidase Substances 0.000 claims description 3
SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 claims description 3
102000003855 L-lactate dehydrogenase Human genes 0.000 claims description 3
108700023483 L-lactate dehydrogenases Proteins 0.000 claims description 3
102000003960 Ligases Human genes 0.000 claims description 3
108090000364 Ligases Proteins 0.000 claims description 3
DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 claims description 3
102000013460 Malate Dehydrogenase Human genes 0.000 claims description 3
108010026217 Malate Dehydrogenase Proteins 0.000 claims description 3
102000010909 Monoamine Oxidase Human genes 0.000 claims description 3
108010062431 Monoamine oxidase Proteins 0.000 claims description 3
102000005348 Neuraminidase Human genes 0.000 claims description 3
108010006232 Neuraminidase Proteins 0.000 claims description 3
108010031852 Pyruvate Synthase Proteins 0.000 claims description 3
102100033220 Xanthine oxidase Human genes 0.000 claims description 3
108010093894 Xanthine oxidase Proteins 0.000 claims description 3
UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 claims description 3
GFFGJBXGBJISGV-UHFFFAOYSA-N adenyl group Chemical group N1=CN=C2N=CNC2=C1N GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 claims description 3
WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims description 3
102000012086 alpha-L-Fucosidase Human genes 0.000 claims description 3
108010061314 alpha-L-Fucosidase Proteins 0.000 claims description 3
108010062636 apomyoglobin Proteins 0.000 claims description 3
108010005774 beta-Galactosidase Proteins 0.000 claims description 3
-1 beta-galactoxidase Proteins 0.000 claims description 3
230000001588 bifunctional effect Effects 0.000 claims description 3
239000007822 coupling agent Substances 0.000 claims description 3
238000010168 coupling process Methods 0.000 claims description 3
125000001295 dansyl group Chemical group [H]C1=C([H])C(N(C([H])([H])[H])C([H])([H])[H])=C2C([H])=C([H])C([H])=C(C2=C1[H])S(*)(=O)=O 0.000 claims description 3
230000005284 excitation Effects 0.000 claims description 3
229930182830 galactose Natural products 0.000 claims description 3
229940116332 glucose oxidase Drugs 0.000 claims description 3
235000019420 glucose oxidase Nutrition 0.000 claims description 3
102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 claims description 3
108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 claims description 3
KNJDBYZZKAZQNG-UHFFFAOYSA-N lucigenin Chemical compound [O-][N+]([O-])=O.[O-][N+]([O-])=O.C12=CC=CC=C2[N+](C)=C(C=CC=C2)C2=C1C1=C(C=CC=C2)C2=[N+](C)C2=CC=CC=C12 KNJDBYZZKAZQNG-UHFFFAOYSA-N 0.000 claims description 3
108020004707 nucleic acids Proteins 0.000 claims description 3
150000007523 nucleic acids Chemical class 0.000 claims description 3
102000039446 nucleic acids Human genes 0.000 claims description 3
125000002080 perylenyl group Chemical group C1(=CC=C2C=CC=C3C4=CC=CC5=CC=CC(C1=C23)=C45)* 0.000 claims description 3
CSHWQDPOILHKBI-UHFFFAOYSA-N peryrene Natural products C1=CC(C2=CC=CC=3C2=C2C=CC=3)=C3C2=CC=CC3=C1 CSHWQDPOILHKBI-UHFFFAOYSA-N 0.000 claims description 3
229940079877 pyrogallol Drugs 0.000 claims description 3
YYMBJDOZVAITBP-UHFFFAOYSA-N rubrene Chemical compound C1=CC=CC=C1C(C1=C(C=2C=CC=CC=2)C2=CC=CC=C2C(C=2C=CC=CC=2)=C11)=C(C=CC=C2)C2=C1C1=CC=CC=C1 YYMBJDOZVAITBP-UHFFFAOYSA-N 0.000 claims description 3
102100026189 Beta-galactosidase Human genes 0.000 claims description 2
230000004913 activation Effects 0.000 claims description 2
150000001718 carbodiimides Chemical group 0.000 claims description 2
150000007942 carboxylates Chemical class 0.000 claims description 2
239000011248 coating agent Substances 0.000 claims description 2
238000000576 coating method Methods 0.000 claims description 2
230000008878 coupling Effects 0.000 claims description 2
229920000620 organic polymer Polymers 0.000 claims description 2
150000004032 porphyrins Chemical group 0.000 claims description 2
239000002243 precursor Substances 0.000 claims description 2
235000007682 pyridoxal 5'-phosphate Nutrition 0.000 claims description 2
239000011589 pyridoxal 5'-phosphate Substances 0.000 claims description 2
229960001327 pyridoxal phosphate Drugs 0.000 claims description 2
125000000311 mannosyl group Chemical group C1([C@@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims 3
FCNCGHJSNVOIKE-UHFFFAOYSA-N 9,10-diphenylanthracene Chemical compound C1=CC=CC=C1C(C1=CC=CC=C11)=C(C=CC=C2)C2=C1C1=CC=CC=C1 FCNCGHJSNVOIKE-UHFFFAOYSA-N 0.000 claims 2
XJLXINKUBYWONI-NNYOXOHSSA-O NADP(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-NNYOXOHSSA-O 0.000 claims 2
125000003158 alcohol group Chemical group 0.000 claims 2
108060006633 protein kinase Proteins 0.000 claims 2
ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical class C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 claims 2
108091009357 vitamin binding proteins Proteins 0.000 claims 2
102000028728 vitamin binding proteins Human genes 0.000 claims 2
CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 claims 1
YPZRHBJKEMOYQH-UYBVJOGSSA-N FADH2 Chemical compound C1=NC2=C(N)N=CN=C2N1[C@@H]([C@H](O)[C@@H]1O)O[C@@H]1COP(O)(=O)OP(O)(=O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C(NC(=O)NC2=O)=C2NC2=C1C=C(C)C(C)=C2 YPZRHBJKEMOYQH-UYBVJOGSSA-N 0.000 claims 1
102000004366 Glucosidases Human genes 0.000 claims 1
108010056771 Glucosidases Proteins 0.000 claims 1
108091008324 binding proteins Proteins 0.000 claims 1
102000023732 binding proteins Human genes 0.000 claims 1
238000009833 condensation Methods 0.000 claims 1
230000005494 condensation Effects 0.000 claims 1
238000004090 dissolution Methods 0.000 claims 1
HFTAFOQKODTIJY-UHFFFAOYSA-N umbelliferone Natural products Cc1cc2C=CC(=O)Oc2cc1OCC=CC(C)(C)O HFTAFOQKODTIJY-UHFFFAOYSA-N 0.000 claims 1
108020004414 DNA Proteins 0.000 description 45
229920001213 Polysorbate 20 Polymers 0.000 description 25
239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 25
239000000243 solution Substances 0.000 description 23
229920000936 Agarose Polymers 0.000 description 19
241000700584 Simplexvirus Species 0.000 description 17
230000002285 radioactive effect Effects 0.000 description 16
108091034117 Oligonucleotide Proteins 0.000 description 15
239000011324 bead Substances 0.000 description 14
230000035945 sensitivity Effects 0.000 description 14
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 13
238000004458 analytical method Methods 0.000 description 13
230000003197 catalytic effect Effects 0.000 description 13
230000000694 effects Effects 0.000 description 11
239000000020 Nitrocellulose Substances 0.000 description 10
230000003622 anti-hsv Effects 0.000 description 10
235000014633 carbohydrates Nutrition 0.000 description 10
229920001220 nitrocellulos Polymers 0.000 description 10
239000000872 buffer Substances 0.000 description 9
238000005406 washing Methods 0.000 description 8
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
108091003079 Bovine Serum Albumin Proteins 0.000 description 7
241000700721 Hepatitis B virus Species 0.000 description 7
229940098773 bovine serum albumin Drugs 0.000 description 7
238000011534 incubation Methods 0.000 description 7
239000011159 matrix material Substances 0.000 description 7
TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 6
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 6
230000008901 benefit Effects 0.000 description 6
238000005415 bioluminescence Methods 0.000 description 6
230000029918 bioluminescence Effects 0.000 description 6
HFJRKMMYBMWEAD-UHFFFAOYSA-N dodecanal Chemical compound CCCCCCCCCCCC=O HFJRKMMYBMWEAD-UHFFFAOYSA-N 0.000 description 6
239000000523 sample Substances 0.000 description 6
239000011780 sodium chloride Substances 0.000 description 6
238000003786 synthesis reaction Methods 0.000 description 6
NBSCHQHZLSJFNQ-GASJEMHNSA-N D-Glucose 6-phosphate Chemical compound OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O NBSCHQHZLSJFNQ-GASJEMHNSA-N 0.000 description 5
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 5
VFRROHXSMXFLSN-UHFFFAOYSA-N Glc6P Natural products OP(=O)(O)OCC(O)C(O)C(O)C(O)C=O VFRROHXSMXFLSN-UHFFFAOYSA-N 0.000 description 5
239000007983 Tris buffer Substances 0.000 description 5
150000002148 esters Chemical class 0.000 description 5
229940045189 glucose-6-phosphate Drugs 0.000 description 5
239000000463 material Substances 0.000 description 5
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 5
MXHRCPNRJAMMIM-SHYZEUOFSA-N 2'-deoxyuridine Chemical group C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 MXHRCPNRJAMMIM-SHYZEUOFSA-N 0.000 description 4
XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 4
150000001298 alcohols Chemical class 0.000 description 4
230000001580 bacterial effect Effects 0.000 description 4
238000003390 bioluminescence detection Methods 0.000 description 4
230000009137 competitive binding Effects 0.000 description 4
230000000295 complement effect Effects 0.000 description 4
230000001419 dependent effect Effects 0.000 description 4
MXHRCPNRJAMMIM-UHFFFAOYSA-N desoxyuridine Natural products C1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 MXHRCPNRJAMMIM-UHFFFAOYSA-N 0.000 description 4
230000002255 enzymatic effect Effects 0.000 description 4
238000009396 hybridization Methods 0.000 description 4
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
239000000203 mixture Substances 0.000 description 4
235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 4
238000011160 research Methods 0.000 description 4
150000003839 salts Chemical class 0.000 description 4
238000011896 sensitive detection Methods 0.000 description 4
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
102000008170 Aldehyde Oxidoreductases Human genes 0.000 description 3
108010060441 Aldehyde Oxidoreductases Proteins 0.000 description 3
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
238000009825 accumulation Methods 0.000 description 3
230000003213 activating effect Effects 0.000 description 3
150000001336 alkenes Chemical class 0.000 description 3
238000003556 assay Methods 0.000 description 3
230000006287 biotinylation Effects 0.000 description 3
238000007413 biotinylation Methods 0.000 description 3
229920002678 cellulose Polymers 0.000 description 3
239000001913 cellulose Substances 0.000 description 3
RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
238000002372 labelling Methods 0.000 description 3
239000007788 liquid Substances 0.000 description 3
238000000504 luminescence detection Methods 0.000 description 3
229910001629 magnesium chloride Inorganic materials 0.000 description 3
BGEHHAVMRVXCGR-UHFFFAOYSA-N methylundecylketone Natural products CCCCCCCCCCCCC=O BGEHHAVMRVXCGR-UHFFFAOYSA-N 0.000 description 3
238000012544 monitoring process Methods 0.000 description 3
230000009871 nonspecific binding Effects 0.000 description 3
150000003901 oxalic acid esters Chemical class 0.000 description 3
239000013612 plasmid Substances 0.000 description 3
229920003023 plastic Polymers 0.000 description 3
239000004033 plastic Substances 0.000 description 3
230000002829 reductive effect Effects 0.000 description 3
239000002002 slurry Substances 0.000 description 3
235000017557 sodium bicarbonate Nutrition 0.000 description 3
229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
239000001509 sodium citrate Substances 0.000 description 3
NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 3
241000894007 species Species 0.000 description 3
239000000725 suspension Substances 0.000 description 3
GEVPIWPYWJZSPR-UHFFFAOYSA-N tcpo Chemical compound ClC1=CC(Cl)=CC(Cl)=C1OC(=O)C(=O)OC1=C(Cl)C=C(Cl)C=C1Cl GEVPIWPYWJZSPR-UHFFFAOYSA-N 0.000 description 3
HSHNITRMYYLLCV-UHFFFAOYSA-N 4-methylumbelliferone Chemical compound C1=C(O)C=CC2=C1OC(=O)C=C2C HSHNITRMYYLLCV-UHFFFAOYSA-N 0.000 description 2
PQGCEDQWHSBAJP-TXICZTDVSA-N 5-O-phosphono-alpha-D-ribofuranosyl diphosphate Chemical compound O[C@H]1[C@@H](O)[C@@H](O[P@](O)(=O)OP(O)(O)=O)O[C@@H]1COP(O)(O)=O PQGCEDQWHSBAJP-TXICZTDVSA-N 0.000 description 2
108020005199 Dehydrogenases Proteins 0.000 description 2
AHCYMLUZIRLXAA-SHYZEUOFSA-N Deoxyuridine 5'-triphosphate Chemical compound O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(=O)NC(=O)C=C1 AHCYMLUZIRLXAA-SHYZEUOFSA-N 0.000 description 2
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
229920001917 Ficoll Polymers 0.000 description 2
108010020056 Hydrogenase Proteins 0.000 description 2
102000004877 Insulin Human genes 0.000 description 2
108090001061 Insulin Proteins 0.000 description 2
101710160107 Outer membrane protein A Proteins 0.000 description 2
108091000080 Phosphotransferase Proteins 0.000 description 2
108020005115 Pyruvate Kinase Proteins 0.000 description 2
IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical group O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
230000002378 acidificating effect Effects 0.000 description 2
150000001408 amides Chemical class 0.000 description 2
BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
229910052921 ammonium sulfate Inorganic materials 0.000 description 2
235000011130 ammonium sulphate Nutrition 0.000 description 2
230000003602 anti-herpes Effects 0.000 description 2
PURKHUDOTFUVNG-UHFFFAOYSA-N bis(2,3,5-trichloro-6-pentoxycarbonylphenyl) oxalate Chemical compound CCCCCOC(=O)C1=C(Cl)C=C(Cl)C(Cl)=C1OC(=O)C(=O)OC1=C(Cl)C(Cl)=CC(Cl)=C1C(=O)OCCCCC PURKHUDOTFUVNG-UHFFFAOYSA-N 0.000 description 2
244000309466 calf Species 0.000 description 2
230000008859 change Effects 0.000 description 2
230000009918 complex formation Effects 0.000 description 2
230000002596 correlated effect Effects 0.000 description 2
230000000875 corresponding effect Effects 0.000 description 2
238000000502 dialysis Methods 0.000 description 2
150000008049 diazo compounds Chemical class 0.000 description 2
238000006911 enzymatic reaction Methods 0.000 description 2
125000000524 functional group Chemical group 0.000 description 2
229940125396 insulin Drugs 0.000 description 2
239000012035 limiting reagent Substances 0.000 description 2
108010029942 microperoxidase Proteins 0.000 description 2
239000002245 particle Substances 0.000 description 2
239000002953 phosphate buffered saline Substances 0.000 description 2
102000020233 phosphotransferase Human genes 0.000 description 2
229920000642 polymer Polymers 0.000 description 2
239000008057 potassium phosphate buffer Substances 0.000 description 2
238000002360 preparation method Methods 0.000 description 2
238000011002 quantification Methods 0.000 description 2
230000005855 radiation Effects 0.000 description 2
238000000163 radioactive labelling Methods 0.000 description 2
239000000941 radioactive substance Substances 0.000 description 2
239000000376 reactant Substances 0.000 description 2
210000002966 serum Anatomy 0.000 description 2
239000002904 solvent Substances 0.000 description 2
230000009870 specific binding Effects 0.000 description 2
238000010561 standard procedure Methods 0.000 description 2
238000012360 testing method Methods 0.000 description 2
150000003568 thioethers Chemical class 0.000 description 2
UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 2
210000001541 thymus gland Anatomy 0.000 description 2
210000001519 tissue Anatomy 0.000 description 2
238000013519 translation Methods 0.000 description 2
YMXHPSHLTSZXKH-RVBZMBCESA-N (2,5-dioxopyrrolidin-1-yl) 5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoate Chemical compound C([C@H]1[C@H]2NC(=O)N[C@H]2CS1)CCCC(=O)ON1C(=O)CCC1=O YMXHPSHLTSZXKH-RVBZMBCESA-N 0.000 description 1
150000003923 2,5-pyrrolediones Chemical class 0.000 description 1
AYXZIZMZXAORLO-UFLZEWODSA-N 5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoic acid;1-hydroxypyrrolidine-2,5-dione Chemical compound ON1C(=O)CCC1=O.N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 AYXZIZMZXAORLO-UFLZEWODSA-N 0.000 description 1
KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical group N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 1
239000004382 Amylase Substances 0.000 description 1
102000013142 Amylases Human genes 0.000 description 1
108010065511 Amylases Proteins 0.000 description 1
229920000945 Amylopectin Polymers 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
BTZDPNRRJCCGEW-UHFFFAOYSA-N C1=CC=C(C=C1)C1=CC2=CC3=CC=CC=C3C(C3=CC=CC=C3)=C2C=C1 Chemical compound C1=CC=C(C=C1)C1=CC2=CC3=CC=CC=C3C(C3=CC=CC=C3)=C2C=C1 BTZDPNRRJCCGEW-UHFFFAOYSA-N 0.000 description 1
241000283707 Capra Species 0.000 description 1
108020004635 Complementary DNA Proteins 0.000 description 1
102000018832 Cytochromes Human genes 0.000 description 1
108010052832 Cytochromes Proteins 0.000 description 1
WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
108020003215 DNA Probes Proteins 0.000 description 1
239000003298 DNA probe Substances 0.000 description 1
XPDXVDYUQZHFPV-UHFFFAOYSA-N Dansyl Chloride Chemical compound C1=CC=C2C(N(C)C)=CC=CC2=C1S(Cl)(=O)=O XPDXVDYUQZHFPV-UHFFFAOYSA-N 0.000 description 1
241000701959 Escherichia virus Lambda Species 0.000 description 1
108010014531 FMN Reductase Proteins 0.000 description 1
101001056976 Halobacterium salinarum (strain ATCC 700922 / JCM 11081 / NRC-1) Catalase-peroxidase Proteins 0.000 description 1
208000009889 Herpes Simplex Diseases 0.000 description 1
241000700588 Human alphaherpesvirus 1 Species 0.000 description 1
241000254158 Lampyridae Species 0.000 description 1
241000192132 Leuconostoc Species 0.000 description 1
241000192130 Leuconostoc mesenteroides Species 0.000 description 1
108060001084 Luciferase Proteins 0.000 description 1
239000005089 Luciferase Substances 0.000 description 1
101800000628 PDH precursor-related peptide Proteins 0.000 description 1
108020004511 Recombinant DNA Proteins 0.000 description 1
229920005654 Sephadex Polymers 0.000 description 1
239000012507 Sephadex™ Substances 0.000 description 1
UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
YZCKVEUIGOORGS-NJFSPNSNSA-N Tritium Chemical compound [3H] YZCKVEUIGOORGS-NJFSPNSNSA-N 0.000 description 1
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
241000607618 Vibrio harveyi Species 0.000 description 1
239000002253 acid Substances 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
230000009471 action Effects 0.000 description 1
230000006978 adaptation Effects 0.000 description 1
230000002411 adverse Effects 0.000 description 1
125000001931 aliphatic group Chemical group 0.000 description 1
235000019418 amylase Nutrition 0.000 description 1
230000000890 antigenic effect Effects 0.000 description 1
125000003118 aryl group Chemical group 0.000 description 1
108010063086 avidin-agarose Proteins 0.000 description 1
239000011230 binding agent Substances 0.000 description 1
238000010804 cDNA synthesis Methods 0.000 description 1
150000004657 carbamic acid derivatives Chemical class 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
210000004027 cell Anatomy 0.000 description 1
239000002738 chelating agent Substances 0.000 description 1
125000003636 chemical group Chemical group 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
238000004737 colorimetric analysis Methods 0.000 description 1
239000002299 complementary DNA Substances 0.000 description 1
238000010668 complexation reaction Methods 0.000 description 1
238000001816 cooling Methods 0.000 description 1
239000007799 cork Substances 0.000 description 1
230000002380 cytological effect Effects 0.000 description 1
RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
238000007865 diluting Methods 0.000 description 1
150000002009 diols Chemical group 0.000 description 1
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
238000010494 dissociation reaction Methods 0.000 description 1
230000005593 dissociations Effects 0.000 description 1
239000012153 distilled water Substances 0.000 description 1
230000002708 enhancing effect Effects 0.000 description 1
230000007613 environmental effect Effects 0.000 description 1
238000012869 ethanol precipitation Methods 0.000 description 1
150000002170 ethers Chemical class 0.000 description 1
239000012847 fine chemical Substances 0.000 description 1
230000004992 fission Effects 0.000 description 1
230000007274 generation of a signal involved in cell-cell signaling Effects 0.000 description 1
239000011521 glass Substances 0.000 description 1
230000005283 ground state Effects 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
208000002672 hepatitis B Diseases 0.000 description 1
229940094991 herring sperm dna Drugs 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
150000002540 isothiocyanates Chemical class 0.000 description 1
230000000155 isotopic effect Effects 0.000 description 1
238000005567 liquid scintillation counting Methods 0.000 description 1
238000005259 measurement Methods 0.000 description 1
150000002730 mercury Chemical class 0.000 description 1
150000002739 metals Chemical class 0.000 description 1
238000002156 mixing Methods 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
239000002773 nucleotide Substances 0.000 description 1
125000003729 nucleotide group Chemical group 0.000 description 1
JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
230000003647 oxidation Effects 0.000 description 1
238000007254 oxidation reaction Methods 0.000 description 1
150000002924 oxiranes Chemical class 0.000 description 1
244000052769 pathogen Species 0.000 description 1
KHIWWQKSHDUIBK-UHFFFAOYSA-M periodate Chemical compound [O-]I(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-M 0.000 description 1
KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical class OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 1
230000000737 periodic effect Effects 0.000 description 1
230000002093 peripheral effect Effects 0.000 description 1
229930029653 phosphoenolpyruvate Natural products 0.000 description 1
DTBNBXWJWCWCIK-UHFFFAOYSA-N phosphoenolpyruvic acid Chemical compound OC(=O)C(=C)OP(O)(O)=O DTBNBXWJWCWCIK-UHFFFAOYSA-N 0.000 description 1
229920000136 polysorbate Polymers 0.000 description 1
239000001267 polyvinylpyrrolidone Substances 0.000 description 1
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
150000003141 primary amines Chemical class 0.000 description 1
230000008569 process Effects 0.000 description 1
238000006862 quantum yield reaction Methods 0.000 description 1
238000007420 radioactive assay Methods 0.000 description 1
239000011541 reaction mixture Substances 0.000 description 1
230000009467 reduction Effects 0.000 description 1
230000000717 retained effect Effects 0.000 description 1
238000012552 review Methods 0.000 description 1
150000003384 small molecules Chemical class 0.000 description 1
239000001488 sodium phosphate Substances 0.000 description 1
229910000162 sodium phosphate Inorganic materials 0.000 description 1
239000012064 sodium phosphate buffer Substances 0.000 description 1
238000005063 solubilization Methods 0.000 description 1
230000007928 solubilization Effects 0.000 description 1
230000003381 solubilizing effect Effects 0.000 description 1
230000002269 spontaneous effect Effects 0.000 description 1
238000010186 staining Methods 0.000 description 1
238000003756 stirring Methods 0.000 description 1
238000003860 storage Methods 0.000 description 1
125000001424 substituent group Chemical group 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
239000010414 supernatant solution Substances 0.000 description 1
230000002194 synthesizing effect Effects 0.000 description 1
238000010189 synthetic method Methods 0.000 description 1
150000007970 thio esters Chemical class 0.000 description 1
150000003585 thioureas Chemical class 0.000 description 1
150000004072 triols Chemical class 0.000 description 1
RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
229910052722 tritium Inorganic materials 0.000 description 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/533—Production of labelled immunochemicals with fluorescent label

Landscapes

Health & Medical Sciences (AREA)
Immunology (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Chemical & Material Sciences (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
Cell Biology (AREA)
Food Science & Technology (AREA)
Medicinal Chemistry (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Microbiology (AREA)
General Health & Medical Sciences (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Immobilizing And Processing Of Enzymes And Microorganisms (AREA)

NO853790A 1984-01-27 1985-09-26 Fremangsmaate for paavisning av immobiliserte raportoergrupper NO853790L (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/US1984/000138 WO1985003356A1 (en)	1984-01-27	1984-01-27	Assay for immobilized reporter groups

Publications (1)

Publication Number	Publication Date
NO853790L true NO853790L (no)	1985-09-26

Family

ID=22182033

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO853790A NO853790L (no)	1984-01-27	1985-09-26	Fremangsmaate for paavisning av immobiliserte raportoergrupper

Country Status (6)

Country	Link
EP (1)	EP0170652A4 (de)
JP (1)	JPS61501047A (de)
AU (1)	AU582341B2 (de)
DK (1)	DK436785D0 (de)
NO (1)	NO853790L (de)
WO (1)	WO1985003356A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU3844485A (en) *	1984-02-09	1985-08-15	Enzo Biochem Inc.	Heterologous detection of cabeled dna
FR2602592B1 (fr) *	1986-08-06	1989-06-30	Alain Baret	Utilisation du systeme enzymatique xanthine-oxydase en immuno-analyse, procedes de dosage correspondants et coffrets de reactifs necessaires pour la mise en oeuvre de ces procedes.
GB8628108D0 (en) *	1986-11-25	1986-12-31	London Biotechnology Ltd	Riboflavin-linked assay
WO1989011544A1 (en) *	1988-05-21	1989-11-30	London Biotechnology Limited	Riboflavin-linked assay procedures and materials
US5888728A (en)	1988-10-17	1999-03-30	Molecular Devices Corporation	Hapten derivatized capture membrane and diagnostic assays using such membrane
AU4883401A (en) *	2000-04-26	2001-11-07	Kikkoman Corporation	Method of measuring biological luminescence

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4383031A (en) *	1975-04-28	1983-05-10	Miles Laboratories, Inc.	Homogeneous chemiluminescent specific binding assay
SE404553B (sv) *	1977-03-04	1978-10-09	Pharmacia Diagnostics Ab	Sett vid bestemningsmetoder involverande biospecifika affinitetsreaktioner
JPS5510590A (en) *	1978-05-04	1980-01-25	Wellcome Found	Enzyme immunity quantity analysis
US4228237A (en) *	1978-09-21	1980-10-14	Calbiochem-Behring Corp.	Methods for the detection and determination of ligands
US4334017A (en) *	1979-04-16	1982-06-08	Massachusetts Institute Of Technology	Method for detecting cancer in mammalian tissue
US4358535A (en) *	1980-12-08	1982-11-09	Board Of Regents Of The University Of Washington	Specific DNA probes in diagnostic microbiology
CA1219824A (en) *	1981-04-17	1987-03-31	David C. Ward	Modified nucleotides and methods of preparing and using same
CA1203164A (en) *	1982-03-09	1986-04-15	Thomas J. Mckearn	Antibody conjugates
DK188184A (da) *	1983-04-20	1984-10-21	Enzo Biochem Inc	Fremgangsmaade til dannelse af et kompleks af biologisk aktive eller funktionelle forbindelser og anvendelse af forbindelserne
JPS607362A (ja) *	1983-06-27	1985-01-16	Fujirebio Inc	酵素を用いた抗原決定基具有物質の測定法
US4737454A (en) *	1983-07-14	1988-04-12	Molecular Diagnostics, Inc.	Fast photochemical method of labelling nucleic acids for detection purposes in hybridization assays
US4582810A (en) *	1983-09-30	1986-04-15	Becton, Dickinson And Company	Immuno-agglutination particle suspensions

1984
- 1984-01-27 WO PCT/US1984/000138 patent/WO1985003356A1/en not_active Application Discontinuation
- 1984-01-27 JP JP59501025A patent/JPS61501047A/ja active Pending
- 1984-01-27 EP EP19840901033 patent/EP0170652A4/de not_active Withdrawn
- 1984-01-27 AU AU25770/84A patent/AU582341B2/en not_active Ceased
1985
- 1985-09-26 DK DK436785A patent/DK436785D0/da not_active Application Discontinuation
- 1985-09-26 NO NO853790A patent/NO853790L/no unknown

Also Published As

Publication number	Publication date
EP0170652A4 (de)	1988-08-23
EP0170652A1 (de)	1986-02-12
JPS61501047A (ja)	1986-05-22
AU2577084A (en)	1985-08-09
DK436785A (da)	1985-09-26
WO1985003356A1 (en)	1985-08-01
DK436785D0 (da)	1985-09-26
AU582341B2 (en)	1989-03-23

Publication	Publication Date	Title
EP0837949B1 (de)	2003-11-12	Elektrochemilumineszente enzymbiosensoren
Blackburn et al.	1991	Electrochemiluminescence detection for development of immunoassays and DNA probe assays for clinical diagnostics
JP3784072B2 (ja)	2006-06-07	電気化学発光酵素イムノアッセイ
EP0093613B1 (de)	1988-08-17	Gleichzeitiges heterogenes Immuntest-Eichungsverfahren, Vorrichtung und diagnostischer Testsatz
JPH0145026B2 (de)	1989-10-02
US4492751A (en)	1985-01-08	Heterogenous specific binding assay employing an enzyme substrate as label
US5223393A (en)	1993-06-29	Detection of analytes having binding sites for at least two binding moieties
JPH09510289A (ja)	1997-10-14	イムノアッセイで使用するための干渉除去剤
JPS6175260A (ja)	1986-04-17	増幅された続取りおよび気相検出を伴う結合アツセイ
JPH0346561A (ja)	1991-02-27	分析物検出のための方法、試薬及び試験ストリップ
NO853790L (no)	1985-09-26	Fremangsmaate for paavisning av immobiliserte raportoergrupper
Morris et al.	1983	[32] Colorimetric immunoassays using flavin adenine dinucleotide as label
WO1989012826A1 (en)	1989-12-28	Vitamin b12 assay
CA2328684A1 (en)	2002-06-15	Photon-triggered luminescent assay
CA1255213A (en)	1989-06-06	Assay for immobilized reporter groups
CA2264448C (en)	2008-10-28	An assay surface that permits an analyte releasing step
Van Bommel et al.	1999	Enzyme amplification as detection tool in continuous-flow systems: II. On-line coupling of liquid chromatography to enzyme-amplified biochemical detection after pre-column derivatization with biotin
JPH0560059B2 (de)	1993-09-01
Luider et al.	1990	Thermochemiluminescence immunoassay for hCG
EP0292171A2 (de)	1988-11-23	Enzym-Immunoassay
JPH11512282A (ja)	1999-10-26	シグナル発生酵素としてバナジウムブロモペルオキシダーゼを使った特異的結合リガンドの測定用の分析要素および方法